| Dilated cardiomyopathy |
2.28 |
0.00e+0 |
86/96 (89.58%) |
TTN;ADCY1;ATP2A2;...
|
| Hypertrophic cardiomyopathy |
2.02 |
4.79e-3 |
81/90 (90%) |
TTN;ATP2A2;TNNC1;...
|
| Regulation of lipolysis in adipocytes |
1.96 |
1.28e-2 |
52/55 (94.55%) |
GNAI1;ADCY1;IRS1;...
|
| GABAergic synapse |
1.93 |
9.58e-3 |
76/89 (85.39%) |
GNAI1;ADCY1;PRKCA;...
|
| Gastric acid secretion |
1.85 |
1.92e-2 |
63/76 (82.89%) |
GNAI1;ADCY1;PRKCA;...
|
| Adrenergic signaling in cardiomyocytes |
1.85 |
2.24e-2 |
130/150 (86.67%) |
GNAI1;ADCY1;ATP2A2;...
|
| Neomycin, kanamycin and gentamicin biosynthesis |
1.82 |
2.19e-2 |
5/5 (100%) |
HK2;HK3
|
| Morphine addiction |
1.81 |
2.16e-2 |
80/91 (87.91%) |
GNAI1;ADCY1;PRKCA;...
|
| Central carbon metabolism in cancer |
1.80 |
2.02e-2 |
67/70 (95.71%) |
SIRT3;RET;HK2;...
|
| Rap1 signaling pathway |
1.75 |
2.97e-2 |
184/210 (87.62%) |
GNAI1;ADCY1;LPAR1;...
|
| ECM-receptor interaction |
1.75 |
2.79e-2 |
80/88 (90.91%) |
COL4A6;COL6A1;LAMA2;...
|
| Protein digestion and absorption |
1.75 |
2.72e-2 |
78/103 (75.73%) |
COL4A6;COL6A1;ATP1A2;...
|
| Relaxin signaling pathway |
1.74 |
2.80e-2 |
114/129 (88.37%) |
GNAI1;ADCY1;COL4A6;...
|
| Melanogenesis |
1.73 |
2.81e-2 |
74/101 (73.27%) |
GNAI1;ADCY1;PRKCA;...
|
| Proteoglycans in cancer |
1.72 |
2.94e-2 |
172/205 (83.9%) |
ANK2;PRKCA;COL1A2;...
|
| Focal adhesion |
1.70 |
3.89e-2 |
180/201 (89.55%) |
COL4A6;COL6A1;PRKCA;...
|
| Viral protein interaction with cytokine and cytokine re... |
-1.71 |
2.07e-2 |
84/100 (84%) |
CXCL5;CCL20;CXCL1;...
|
| Phagosome |
-1.73 |
1.74e-2 |
118/152 (77.63%) |
FCGR3B;SEC61G;MSR1;...
|
| Protein processing in endoplasmic reticulum |
-1.74 |
1.65e-2 |
127/171 (74.27%) |
EIF2S1;SEC24B;SAR1A;...
|
| NOD-like receptor signaling pathway |
-1.76 |
1.36e-2 |
145/181 (80.11%) |
GABARAPL2;DEFA6;HSP90AA1;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.79 |
1.21e-2 |
49/77 (63.64%) |
CYP1B1;UGT2B15;CYP3A5;...
|
| Protein export |
-1.80 |
1.13e-2 |
17/23 (73.91%) |
SEC11A;SEC61G;SRPRA;...
|
| Primary bile acid biosynthesis |
-1.81 |
1.14e-2 |
15/17 (88.24%) |
ACOX2;SLC27A5;CYP7B1;...
|
| TNF signaling pathway |
-1.83 |
9.59e-3 |
103/112 (91.96%) |
DNM1L;CHUK;BIRC2;...
|
| Amyotrophic lateral sclerosis |
-1.84 |
9.55e-3 |
267/364 (73.35%) |
NDUFA10;SDHC;NDUFA4L2;...
|
| Coronavirus disease |
-1.84 |
1.00e-2 |
215/232 (92.67%) |
RPS10;PLCG2;RPL41;...
|
| Kaposi sarcoma-associated herpesvirus infection |
-1.84 |
1.05e-2 |
172/193 (89.12%) |
IFNA16;IFNA5;AKT2;...
|
| Alzheimer disease |
-1.84 |
1.05e-2 |
279/369 (75.61%) |
APH1B;CSNK2A2;RTN4;...
|
| Autoimmune thyroid disease |
-1.86 |
9.34e-3 |
46/53 (86.79%) |
HLA-E;HLA-DQA1;HLA-A;...
|
| Type I diabetes mellitus |
-1.90 |
6.80e-3 |
38/43 (88.37%) |
HLA-G;CD28;IL1B;...
|
| Ascorbate and aldarate metabolism |
-1.94 |
6.57e-3 |
15/30 (50%) |
AKR1A1;KL;UGT2B15;...
|
| Allograft rejection |
-1.95 |
7.00e-3 |
32/38 (84.21%) |
HLA-E;HLA-DQA1;HLA-A;...
|
| Prion disease |
-2.01 |
4.50e-3 |
209/273 (76.56%) |
CSNK2A2;NDUFA10;SDHC;...
|
| Non-alcoholic fatty liver disease |
-2.03 |
3.23e-3 |
126/155 (81.29%) |
NDUFA10;SDHC;AKT2;...
|
| Retinol metabolism |
-2.06 |
1.75e-3 |
41/68 (60.29%) |
RDH16;CYP2W1;RETSAT;...
|
| Graft-versus-host disease |
-2.09 |
9.55e-4 |
32/42 (76.19%) |
KLRD1;HLA-G;CD28;...
|
| Antigen processing and presentation |
-2.10 |
1.05e-3 |
60/78 (76.92%) |
KLRC3;NFYA;TAPBP;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-2.15 |
1.17e-3 |
62/70 (88.57%) |
HBEGF;LYN;CDC42;...
|
| Huntington disease |
-2.17 |
1.31e-3 |
233/306 (76.14%) |
NDUFA10;SDHC;NDUFA4L2;...
|
| Proteasome |
-2.20 |
1.50e-3 |
44/46 (95.65%) |
SEM1;PSMB4;PSMB1;...
|
| Rheumatoid arthritis |
-2.27 |
0.00e+0 |
78/93 (83.87%) |
JUN;CD28;IL1B;...
|
| Legionellosis |
-2.29 |
0.00e+0 |
51/57 (89.47%) |
C3;HBS1L;HSPA2;...
|
| Parkinson disease |
-2.29 |
0.00e+0 |
176/249 (70.68%) |
TH;NDUFA10;SDHC;...
|
| IL-17 signaling pathway |
-2.41 |
0.00e+0 |
84/94 (89.36%) |
RELA;MMP9;CXCL6;...
|
| Ribosome |
-2.46 |
0.00e+0 |
113/158 (71.52%) |
RPS3A;MRPL11;MRPL16;...
|
| Oxidative phosphorylation |
-2.69 |
0.00e+0 |
93/133 (69.92%) |
ATP6V1B2;COX11;NDUFA10;...
|
